Congenital pulmonary airway malformation
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
Congenital pulmonary airway malformations (CPAM) are multicystic masses of segmental lung tissue with abnormal bronchial proliferation. CPAMs are considered part of the spectrum of bronchopulmonary foregut malformations.
Until recently, they were described as congenital cystic adenomatoid malformations (CCAM).
They account for ~25% of congenital lung lesions. The estimated incidence is approximately 1:1500-4000 live births and there is a male predominance.
The diagnosis is usually either made on antenatal ultrasound, or in the neonatal period on the investigation of progressive respiratory distress 3,4. If large, they may cause pulmonary hypoplasia, with resultant poor prognosis.
In cases where the abnormality is small, the diagnosis may not be made for many years or even until adulthood. When it does become apparent, it is usually as a result of recurrent chest infection 3,4.
The condition results from failure of normal bronchoalveolar development with a hamartomatous proliferation of terminal respiratory units in a gland-like pattern (adenomatoid) without proper alveolar formation.
Histologically, they are characterized by adenomatoid proliferation of bronchiole-like structures and macro- or microcysts lined by columnar or cuboidal epithelium and absence of cartilage and bronchial glands.
These lesions have intracystic communications and, unlike bronchogenic cysts, can also have a connection to the tracheobronchial tree.
Five subtypes are currently classified, mainly according to cyst size:
most common: 70% of cases 3
large cysts, lined by pseudo-stratified columnar epithelium15
one or more dominant cysts: 2-10 cm in size
may be surrounded by smaller cysts
~10% of cases
microcysts: <5 mm in diameter
typically involves an entire lobe
has a poorer prognosis
large cysts (typically > 10cm) lined by flattened epithelium (type 1 and 2 pneumocytes)15
typically affects a single lobe
indistinguishable from type I on imaging 11
very rare, lethal postnatally
acinar dysgenesis or dysplasia 11
represents global arrest of lung development 12
Lesions are usually unilateral and involve a single lobe. Although there is no well-documented lobar predilection, they appear less frequently in the middle lobe 3.
The appearance of CPAMs will vary depending on the type.
CPAM appears as an isolated cystic or solid intrathoracic mass. A solid thoracic mass is usually indicative of a type III CPAM and is typically hyperechoic. There can be a mass effect where the heart may appear displaced to the opposite side. Alternatively, the lesion may remain stable in size, or even regress 5.
Chest radiographs in type I and II CPAMs may demonstrate a multicystic (air-filled) lesion. Large lesions may cause a mass effect with resultant mediastinal shift, depression, and even inversion of the diaphragm. In the early neonatal period, the cysts may be completely or partially fluid-filled, in which case the lesion may appear solid or with air-fluid levels. Lesions may change in size on interval imaging (expand from collateral ventilation via pores of Kohn). Type III lesions appear solid.
CT has a number of roles in the management of CPAMs. First, it more accurately delineates the location and extent of the lesion. Secondly, and most important in surgical candidates, CT angiography is able to identify systemic arterial supply if present.
Appearance reflects the underlying type, and a type III lesion can appear as a consolidation.
Treatment and prognosis
There is a wide spectrum of prognosis.
Surgery (elective lobectomy) is the treatment of choice in symptomatic patients, both in those presenting early with respiratory compromise and in those presenting later with recurrent infections 3. Type I lesions have the best prognosis.
In the setting of a small stable asymptomatic lesion, surgical excision is more controversial. Advocates for excision quote the reported risk of developing malignancies within the lesion (see above). An alternative approach is to watch and wait. There are reports of spontaneous regression, particularly in those serially followed up on antenatal ultrasound 7,10.
Potential postnatal complications include:
possible incidence of certain malignancies, which include 3:
Potential in utero complications include:
hydrops fetalis may rarely develop when there is severe compression of the fetal heart or great vessels
compression of the normal fetal lung can also rarely cause pulmonary hypoplasia
General imaging differential considerations include:
does not usually communicate with the bronchial tree, and are therefore typically not air-filled
systemic arterial supply
hybrid lesions may present with both CPAM and sequestration features (see above)
bowel loops within a hemithorax
congenital lobar emphysema (congenital lobar overinflation)
hyperlucent and hyperinflated lung segment
no cystic or solid components
localized congenital cystic bronchiectasis
For type I lesions on CT also consider:
- 1. Rosado-de-christenson ML, Stocker JT. Congenital cystic adenomatoid malformation. Radiographics. 1991;11 (5): 865-86. Radiographics (abstract) - Pubmed citation
- 2. Berrocal T, Madrid C, Novo S et-al. Congenital anomalies of the tracheobronchial tree, lung, and mediastinum: embryology, radiology, and pathology. Radiographics. 24 (1): e17. doi:10.1148/rg.e17 - Pubmed citation
- 3. Gross GW. Pediatric chest imaging. Curr Opin Radiol. 1992;4 (5): 36-43. Pubmed citation
- 4. Collins J, Stern EJ. Chest radiology, the essentials. Lippincott Williams & Wilkins. (2007) ISBN:0781763142. Read it at Google Books - Find it at Amazon
- 5. Evans MI. Prenatal diagnosis. McGraw-Hill Professional. (2006) ISBN:0838576826. Read it at Google Books - Find it at Amazon
- 6. Lee EY, Boiselle PM, Cleveland RH. Multidetector CT evaluation of congenital lung anomalies. Radiology. 2008;247 (3): 632-48. doi:10.1148/radiol.2473062124 - Pubmed citation
- 7. Entezami M, Albig M, Knoll U et-al. Ultrasound Diagnosis of Fetal Anomalies. Thieme. (2003) ISBN:1588902129. Read it at Google Books - Find it at Amazon
- 8. Chen WS, Yeh GP, Tsai HD et-al. Prenatal diagnosis of congenital cystic adenomatoid malformations: evolution and outcome. Taiwan J Obstet Gynecol. 2009;48 (3): 278-81. doi:10.1016/S1028-4559(09)60304-1 - Pubmed citation
- 9. Ierullo AM, Ganapathy R, Crowley S et-al. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations. Ultrasound Obstet Gynecol. 2005;26 (2): 150-3. doi:10.1002/uog.1920 - Pubmed citation
- 10. Tran H, Fink MA, Crameri J et-al. Congenital cystic adenomatoid malformation: monitoring the antenatal and short-term neonatal outcome. Aust N Z J Obstet Gynaecol. 2008;48 (5): 462-6. doi:10.1111/j.1479-828X.2008.00887.x - Pubmed citation
- 11. Biyyam DR, Chapman T, Ferguson MR et-al. Congenital lung abnormalities: embryologic features, prenatal diagnosis, and postnatal radiologic-pathologic correlation. Radiographics. 2010;30 (6): 1721-38. doi:10.1148/rg.306105508 - Pubmed citation
- 12. Kao SW, Zuppan CW, Young LW. AIRP best cases in radiologic-pathologic correlation: type 2 congenital cystic adenomatoid malformation (type 2 congenital pulmonary airway malformation). Radiographics. 2011;31 (3): 743-8. doi:10.1148/rg.313105162 - Pubmed citation
- 13. Murphy JP, Ostlie DJ. Ashcraft's Pediatric Surgery (Expert Consult Title: Online + Print). Saunders. ISBN:B00IGM5R52. Read it at Google Books - Find it at Amazon
- 14. Priest JR, Williams GM, Hill DA et-al. Pulmonary cysts in early childhood and the risk of malignancy. Pediatr. Pulmonol. 2009;44 (1): 14-30. doi:10.1002/ppul.20917 - Pubmed citation
- 15. Pooja A. Mehta & Girish Sharma. Congenital Pulmonary Airway Malformation. StatPearls Publishing. 2023. https://www.ncbi.nlm.nih.gov/books/NBK551664/ - Pubmed